From the new year, a pharmacy counter in Australia will carry a payment for the youngest patients it has yet been paid to serve, a small administrative change that reflects a larger worry about whether children are reaching the protections a community depends on. The shift is about money, yet its reach depends on the patchwork of state and territory laws that still decide who may hold the needle and where. Behind the funding line lies a slow erosion, with fewer toddlers fully vaccinated than five years ago and measles pressing at the edges of what Australia had kept at bay. Pharmacists are bei
NIPVIP Expands to Under-5s from 1 January: What Pharmacists Need to Know
Pharmacists are about to become an important access point for early childhood vaccination.
So what actually changes on 1 January? Is it that pharmacists can suddenly vaccinate toddlers?
Not exactly. It's a funding change. Pharmacies can claim the $20.55 NIPVIP payment for NIP vaccines given to children under 5, where state law already allows the vaccinating.
Which is the catch. The headline sounds national, but authority is a patchwork. Queensland and South Australia already allow it, NSW has announced it, and the ACT, Tasmania, WA, Victoria and the NT had announced nothing at the time of writing.
So parents in some states won't see any difference?
Possibly not at first. And even where it's allowed, location matters. Childcare centres and outreach clinics aren't claimable, only pharmacies and certain aged care and disability settings.
Why is the government doing this now?
Coverage has been falling. Fully vaccinated 12-month-olds dropped from 94.8% in 2020 to 90.5% in 2025, and nearly 2 in 5 children got their first MMR dose late.
Worth noting the article doesn't say pharmacy access will reverse that. It's the stated rationale, not a demonstrated result. Also, the measles-status warning is Professor Naunton's conditional: if outbreaks are sustained, it's possible.
What about the pharmacists themselves?
Training is a real gap. Most of it has focused on older children and adults, and infants need different techniques, plus often several vaccines at once.
And the NCIRS finding that pharmacists feel confident in their skills but want help with communication. That's survey data, not a measure of how they'll perform with hesitant parents.
The guidelines revision is due June 2027, with interim guidance before then. The aged care off-site funding is only confirmed to the same month.
Il Polso
- Vaccination coverage for 12-month-olds has slipped from 94.8% to 90.5%, and measles outbreaks are testing Australia's elimination status.
- From 1 January 2027, pharmacies can claim $20.55 per dose for NIP vaccines given to children under 5, but only where state law allows it.
- Queensland and South Australia are ready, NSW joins on 1 January, and most other jurisdictions have yet to say whether they will follow.
- Claims exclude outreach clinics, childcare centres and workplaces, and aged care funding is secure only until June 2027.
- Pharmacists face a training gap for infants and hesitant parents, and PSA's revised guidelines are not due until June 2027, with interim guidance arriving first.
From the new year, a pharmacy counter in Australia will carry a payment for the youngest patients it has yet been paid to serve, a small administrative change that reflects a larger worry about whether children are reaching the protections a community depends on. The shift is about money, yet its reach depends on the patchwork of state and territory laws that still decide who may hold the needle and where. Behind the funding line lies a slow erosion, with fewer toddlers fully vaccinated than five years ago and measles pressing at the edges of what Australia had kept at bay. Pharmacists are being asked to step closer to the earliest stage of childhood, and the profession is still learning how to meet that responsibility with both skill and patience.
From 1 January 2027, a community pharmacy in Australia can claim a government payment for giving a National Immunisation Program vaccine to a child under 5. Until now the NIPVIP payment has only covered patients aged 5 and over. The $41.2 million federal expansion removes that age floor, so participating pharmacies may claim for eligible patients of any age, as long as the other program rules are met.
What a pharmacist can actually do on that date depends on where they work. Queensland pharmacists already vaccinate children under 5 with Queensland Health-funded stock. South Australia dropped its age and location limits in 2025, though no service fee was payable until now. NSW will allow NIP vaccines for under-5s from 1 January. Several other jurisdictions had announced no changes at the time of writing.
Location still limits what can be claimed. Payments apply only to vaccines given in community pharmacies or off-site in residential aged care and disability homes. Outreach clinics, childcare centres and workplaces are not claimable, even where state law permits. Funding for the off-site aged care and disability work runs only to June 2027.
The urgency comes from falling coverage. Fully vaccinated 12-month-olds dropped from 94.8% in 2020 to 90.5% in 2025, and nearly two in five children received their first MMR dose late. South Australia has recorded a measles outbreak this year, and PSA's National President warned that losing Australia's measles-free status is quite possible if outbreaks persist. The expansion sits alongside an enhanced childhood immunisation campaign and SMS reminders to parents of overdue children.
The skills question is still open. Most pharmacist immunisation training has focused on older patients. A review co-authored by Associate Professor Fei Sim recommends training in infant anatomy, age-specific injection technique, consent and managing adverse events in young children. Pharmacists also face hesitant parents, and a 2025 survey found over half of parents of partially vaccinated children considered vaccines unsafe. PSA is preparing interim guidance now and a revised edition of its Practice Guidelines in June 2027, and Sim has invited pharmacists to share their experience, because the strongest guidance is built with the profession rather than handed down to it.
From 1 January 2027, a community pharmacy in Australia will be able to claim a government payment for giving a National Immunisation Program vaccine to a child under 5. Until now, the payment under the National Immunisation Program Vaccinations in Pharmacy program, known as NIPVIP, has only been available for patients aged 5 and over. The federal government's $41.2 million expansion removes that age limit, so participating pharmacies can claim for eligible patients of any age, provided all other program requirements are met.
The change is, in a narrow sense, about funding. It does not alter what pharmacists are legally allowed to do in each state and territory. But several jurisdictions are revising their authorities and scaling up vaccine supply chains ahead of the date, so what a pharmacist can do on 1 January depends heavily on where they practise.
Queensland pharmacists can already vaccinate children under 5 using Queensland Health Immunisation Program-funded stock, and NIPVIP claims will be available from 1 January. South Australia removed all age and location restrictions in January 2025, though no NIPVIP service fee has been payable until now. In the ACT, NSW, Tasmania and WA, pharmacists can currently give influenza vaccines to children from 2 years of age. NSW announced in September that from 1 January its pharmacists will be able to administer NIP vaccines, including to children under 5. At the time of writing, the ACT, Tasmania, WA, Victoria and the Northern Territory had announced no changes ahead of the date.
Location still limits what can be claimed. NIPVIP payments apply only to vaccines given in a community pharmacy, or off-site in residential aged care and disability homes. Vaccinations at outreach clinics, childcare centres or workplaces are not claimable, even where state or territory law lets pharmacists vaccinate there. Queensland is the example: pharmacists may vaccinate at any safe and appropriate location, but not all of those sites qualify for a payment. Participating pharmacies receive $20.55 per vaccination, indexed each year, and from 1 January that applies at any age. Funding for the off-site aged care and disability work is confirmed only until June 2027, with continuation subject to review.
The reason for the expansion is a slide in coverage. The proportion of fully vaccinated 12-month-olds fell from 94.8% in 2020 to 90.5% in 2025. The National Centre for Immunisation Research and Surveillance (NCIRS) found nearly 2 in 5 children received their first measles-mumps-rubella dose late. Countries including the United States have lost measles elimination status, and South Australia recorded a measles outbreak this year. PSA National President Professor Mark Naunton told 7News that if outbreaks are sustained, losing Australia's measles-free status is quite possible. The expansion sits alongside other Budget measures: an enhanced childhood immunisation campaign, plus SMS reminders and targeted information for families, with the texts going to parents of children overdue for one or more vaccines.
Catch-up vaccination varies too. Under Queensland and South Australian authorities it is within current legal authority, provided the pharmacist immuniser is competent in it. That will not necessarily hold elsewhere: in NSW, children needing catch-up vaccines and people with complex medical conditions will not be eligible through a pharmacist under the new arrangements. NIP-funded catch-up is available to people under 20 (26 for HPV), with pharmacist authority subject to local regulation. All state health departments also run catch-up programs for MMR for adults over 20 born after 1966, though these are not funded under the NIP or NIPVIP.
Skills are the other question. Most pharmacist immunisation training has focused on older children and adults. A recent review co-authored by PSA Board Member Associate Professor Fei Sim recommends training in younger children's anatomy, age-specific injection techniques, consent, and managing adverse events in infants. Young children often need several vaccines at once, and conversations with hesitant parents add complexity. In a 2025 NCIRS survey, more than half of parents of partially vaccinated children said vaccines were unsafe and that they did not trust vaccine information from healthcare providers. A separate NCIRS study this year found pharmacist immunisers confident in their skills but wanting more support with communication, including scenario-based training on misinformation and emotional concerns.
PSA is reviewing its Practice Guidelines for immunisation services, with a revised edition expected in June 2027, and will issue interim guidance for the expansion in the meantime. Sim, who chairs the guidelines advisory group, urged pharmacists to share their experiences, saying the strongest professional guidance is developed with the profession, not for it.
Citazioni salienti
The strongest professional guidance is developed with the profession, not for the profession.— Associate Professor Fei Sim, chair of PSA's immunisation guidelines advisory group
If outbreaks are sustained, it is quite possible Australia loses its measles-free status.— Prof Mark Naunton, PSA National President, to 7News (paraphrased)